About 4dmedical ltd - FDMDF
4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. It develops pipeline products that may assist physicians to more effectively diagnose and manage patients with lung disease, which includes XV ventilation analysis, ventilation perfusion, contrast free pulmonary angiography, small animal ventilator, and preclinical scanner. The company was founded by Andreas Fouras in December 2012 and is headquartered in Carlton, Australia.
FDMDF At a Glance
4DMedical Ltd.
Level 7
Carlton, Victoria (VIC) 3053
| Phone | 61-3-9545-5940 | Revenue | 4.79M | |
| Industry | Information Technology Services | Net Income | -138,530,461.70 | |
| Sector | Technology Services | 2026 Sales Growth | 26.227% | |
| Fiscal Year-end | 06 / 2027 | Employees | 181 | |
| View SEC Filings |
FDMDF Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 351.941 |
| Price to Book Ratio | 15.908 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -42.547 |
| Enterprise Value to Sales | 313.314 |
| Total Debt to Enterprise Value | 0.005 |
FDMDF Efficiency
| Revenue/Employee | 26,436.826 |
| Income Per Employee | -765,361.667 |
| Receivables Turnover | 0.73 |
| Total Asset Turnover | 0.03 |
FDMDF Liquidity
| Current Ratio | 30.792 |
| Quick Ratio | 30.769 |
| Cash Ratio | 29.518 |
FDMDF Profitability
| Gross Margin | -539.23 |
| Operating Margin | -813.684 |
| Pretax Margin | -2,977.163 |
| Net Margin | -2,895.059 |
| Return on Assets | -87.888 |
| Return on Equity | -173.178 |
| Return on Total Capital | -110.272 |
| Return on Invested Capital | -163.825 |
FDMDF Capital Structure
| Total Debt to Total Equity | 6.562 |
| Total Debt to Total Capital | 6.158 |
| Total Debt to Total Assets | 3.056 |
| Long-Term Debt to Equity | 5.959 |
| Long-Term Debt to Total Capital | 5.592 |